NCT00685334 Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa Status COMPLETED Phase PHASE4
NCT00678457 Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial Status COMPLETED Phase PHASE2
NCT00645099 A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00632645 Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride Status COMPLETED Phase PHASE3
NCT00625170 Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans Status COMPLETED Phase NA
NCT00621998 Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia Status COMPLETED Phase PHASE4
NCT00618748 Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed Status COMPLETED Phase PHASE3
NCT00615433 Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia Status COMPLETED Phase PHASE3
NCT00568672 Optimal Duration of Olanzapine Add-on Therapy in Major Depression Status WITHDRAWN Phase PHASE3
NCT00520507 An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients Status COMPLETED Phase PHASE4
NCT00510211 An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. Status COMPLETED Phase N/A
NCT00490971 A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder Status COMPLETED Phase PHASE3